Products

EMARKETER delivers leading-edge research to clients in a variety of forms, including full-length reports and data visualizations to equip you with actionable takeaways for better business decisions.
PRO+
New data sets, deeper insights, and flexible data visualizations.
Learn More
Reports
In-depth analysis, benchmarks and shorter spotlights on digital trends.
Learn More
Forecasts
Interactive projections with 10k+ metrics on market trends, & consumer behavior.
Learn More
Charts
Proprietary data and over 3,000 third-party sources about the most important topics.
Learn More
Industry KPIs
Industry benchmarks for the most important KPIs in digital marketing, advertising, retail and ecommerce.
Learn More
Briefings
Client-only email newsletters with analysis and takeaways from the daily news.
Learn More
Analyst Access Program
Exclusive time with the thought leaders who craft our research.
Learn More

About EMARKETER

Our goal is to unlock digital opportunities for our clients with the world’s most trusted forecasts, analysis, and benchmarks. Spanning five core coverage areas and dozens of industries, our research on digital transformation is exhaustive.
Our Story
Learn more about our mission and how EMARKETER came to be.
Learn More
Methodology
Rigorous proprietary data vetting strips biases and produces superior insights.
Learn More
Our People
Take a look into our corporate culture and view our open roles.
Join the Team
Contact Us
Speak to a member of our team to learn more about EMARKETER.
Contact Us
Newsroom
See our latest press releases, news articles or download our press kit.
Learn More
Advertising & Sponsorship Opportunities
Reach an engaged audience of decision-makers.
Learn More
Events
Browse our upcoming and past events, recent podcasts, and other featured resources.
Learn More
Podcasts
Tune in to EMARKETER's daily, weekly, and monthly podcasts.
Learn More

GoodRx reports record Q2 revenue—here's where we think it's headed next

The news: Prescription discount platform GoodRx raked in nearly $177 million in Q2 2021 revenues, marking a 43% increase from Q2 2020.

  • Its platform’s total monthly active users grew to more than 6 million during Q2 2021, which represented a 36% jump from its 4.4 million users during the same period last year.

How we got here: GoodRx has made a slew of strategic partnerships and M&A deals within the past year that played a central role in helping it stay ahead of its competitors, according to the company.

  • In April 2021, GoodRx finalized its acquisition of competitor RxSaver for $50 million to expand its consumer footprint. The company didn’t stop there, though: during the same month, GoodRx announced plans to scoop up health video company HealthiNation to boost consumer health literacy engagement.
  • This month, GoodRx partnered with e-prescription giant Surescripts to give Surescripts’ clients, which include providers at health systems, access to GoodRx's discount pricing within their EHRs. During its Q2 earnings call, GoodRx’s co-founder and co-CEO Trevor Bezdek said it receives most of its consumer traffic through prescribers who recommend its platform—which means its Surescripts partnership should help it considerably widen its consumer base over the next year. For instance, Surescripts claims it delivered nearly 2 billion prescription interactions on its platform last year alone.

What’s next? Out-of-pocket medical spending has reached an all-time high and continues to grow—which means that discount prescription platforms like GoodRx could attract new business from patients seeking less expensive options.

  • The steady rise in chronic health conditions has already contributed to $492 billion in out-of-pocket costs for Americans in 2021, a figure that’s only expected to increase over the next few years. Out-of-pocket spending is expected to rise by nearly 10% by 2026, per a recent Kalorama Information report.
  • That means more consumers will be on the hunt for prescription discounts, especially if they haven’t met their costly deductible on their insurance plan to receive discounts on meds: In 2019, the average individual deductible was nearly $2,000, per KFF.
  • Prescription discount companies like GoodRx and Blink Health are in a prime position to retain consumers, since they often boast lower drug prices than many health insurance plans. For example, GoodRx touts its prices beat insurer prices by more than 50%: It claims its price for one prescription of anxiety drug Lorazepam is $8.84, while a typical insurer would charge an out-of-pocket charge of $23.